Stay updated on LN-144 Clinical Trial in Metastatic Melanoma
Sign up to get notified when there's something new on the LN-144 Clinical Trial in Metastatic Melanoma page.

Latest updates to the LN-144 Clinical Trial in Metastatic Melanoma page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe screenshots show only minor formatting updates and a new last updated timestamp; no core content changes to the study details, eligibility criteria, outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedLocation region and address updates to Auvergne-Rhône-Alpes with a new version tag v3.2.0; added government operating-status notice.SummaryDifference4%

- Check46 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top element has been removed. No other substantive changes to core content, pricing, stock availability, or time-sensitive information.SummaryDifference0.1%

- Check67 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%

- Check74 days agoChange DetectedThe webpage has been updated to include new facility names and locations across various regions in Europe, as well as specific drug information related to Lifileucel. Additionally, the revision number has been updated to v3.0.0.SummaryDifference5%

Stay in the know with updates to LN-144 Clinical Trial in Metastatic Melanoma
Enter your email address, and we'll notify you when there's something new on the LN-144 Clinical Trial in Metastatic Melanoma page.